Moderna stock forecast 2025.

The average Moderna stock price prediction forecasts a potential upside of 84.95% from the current MRNA share price of $78.52. What is MRNA's forecast return on equity (ROE) for 2023-2026? ( NASDAQ : MRNA ) forecast ROE is N/A , which is considered weak .The stock projection varied from the low of $135 to the high of $506. The average price target represents a 35.93% upside from the latest trading price of $233.70 (12 January). According to the algorithmic forecasting of Wallet Investor, as of 10 January 2022, the Moderna stock market price could increase to $570.661 by January 2025 ...According to the issued ratings of 18 analysts in the last year, the consensus rating for Moderna stock is Hold based on the current 3 sell ratings, 9 hold ratings and 6 …Moderna Inc Free Cash Flow Forecast for 2023 - 2025 - 2030. In the last three years, Moderna Inc's Free Cash Flow has grown from $-491.00M to $4.70B – a 1056.62% increase. In the following year, 5 experts forecast that Moderna Inc's Free Cash Flow will decrease by 194.93%, to $-4.46B. Over the next eight years, the forecast is for Free Cash ...Oct 15, 2020 · The Moderna stock forecast is 190.7905902582 USD for 2024 December 04, Wednesday; and 777.709 USD for 2028 December 04, Monday with technical analysis. Moderna (MRNA) stock price prediction is 190.7905902582 USD.

If yes, then on this page you will find useful information about the dynamics of the Moderna stock price in 2023, 2024, 2025, 2026, 2027. How much will one Moderna share be worth in 2023 - 2027? When should I take profit in Moderna stock? When should I record a loss on Moderna stock? What are analysts' forecasts for Moderna stock?What is the forecast for Carnival stock in 2025? Due to the significant decline in the stock price year-to-date, many analysts are turning positive on Carnival as well as other cruise line stocks ...ECL Stock 12 Months Forecast. $194.50. (11.29% Upside) Based on 12 Wall Street analysts offering 12 month price targets for Ecolab in the last 3 months. The average price target is $194.50 with a high forecast of $215.00 and a low forecast of $180.00. The average price target represents a 11.29% change from the last price of $174.77.

Airfinity’s forecasts show BioNTech/Pfizer generating sales of $31.3bn and Moderna $17.6bn in 2021, which is slightly below company projections for $33.5bn and $20bn respectively. It said ...Moderna Inc. analyst ratings, historical stock prices, earnings estimates & actuals. MRNA updated stock price target summary.

Apr 5, 2022 · Cantor Fitzgerald lowered their price target on shares of Novavax from $282.00 to $174.00 and set an “overweight” rating on the stock in a report on Monday, February 14th. StockNews.com ... The Moderna stock price gained 0.592% on the last trading day (Tuesday, 28th Nov 2023), rising from $77.72 to $78.18.During the last trading day the stock fluctuated 3.18% from a day low at $75.84 to a day high of $78.25.The price has risen in 7 of the last 10 days and is up by 11.35% over the past 2 weeks. Volume fell on the last day by -786 …Oct 6, 2020 · MRNA : MODERNA INC stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis MRNA Stock 12 Months Forecast. $123.23. (59.77% Upside) Based on 14 Wall Street analysts offering 12 month price targets for Moderna in the last 3 months. The average price target is $123.23 with a high forecast of $231.00 and a low forecast of $52.00. The average price target represents a 59.77% change from the last price of $77.13.

Moderna. Market Cap. $30B. Today's Change. (0.45%) $0.35. Current Price. $78.52. Price as of November 24, 2023, 1:00 p.m. ET. You’re reading a free article with opinions that may differ from The ...

The performance of Moderna can be bullish in 2025 but it will hardly touch the recent ATH. By 2025, we may expect an average price of $449.83 for Moderna stock. If current growth continues, our maximum forecast for Moderna is $505.46 in 2025. The minimum price level of Moderna can be around $371.86 if the market turns bearish.

If yes, then on this page you will find useful information about the dynamics of the Moderna stock price in 2023, 2024, 2025, 2026, 2027. How much will one Moderna share be worth in 2023 - 2027? When should I take profit in Moderna stock? When should I record a loss on Moderna stock? What are analysts' forecasts for Moderna stock?Nov 2, 2023 · By Patrick Wingrove and Leroy Leo. (Reuters) -Moderna on Thursday said its 2023 sales would only hit the low end of its $6 billion to $8 billion forecast, reflecting weaker demand for COVID-19 ... Moderna is sticking by its forecast range for 2023 Covid-19 vaccine sales, after rival Pfizer cut the sales outlook for its own shot. Moderna shares were still down more than 6% in midday trading ...MODERNA Stock Forecast, 0QF stock price prediction. Price target in 14 days: 72.954 EUR. The best long-term & short-term MODERNA share price prognosis for 2023, 2024 ... Moderna, Inc. (MRNA) stock forecast and price target. Find the latest Moderna, Inc. MRNA analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. In 2025, MRNA is forecast to generate $2,456,440,064,578 in revenue, with the lowest revenue forecast at $1,935,269,070,989 and the highest revenue forecast at …

Dec 28, 2021 · Moderna stock currently trades at a mere 12x 2021 consensus earnings. The conservative multiple is largely due to the fact that investors expect sales of the Covid vaccine – Moderna’s only ... Moderna will start 2025 at $99.88, then soar to $100.71 within the first six months of the year and finish 2025 at $113.03. That means +41% from today. Moderna Stock Forecast 2030-2034. In this period, the Moderna price would rise from $201.67 to $252.73, which is +25%.The past few years may seem like the best of times for Moderna (MRNA-1.02%).The company launched its very first product: the coronavirus vaccine. And thanks to that product, Moderna brought in ...Oct 28, 2023 · On the flip side, the floor value that Moderna stock may plummet to in 2025 is $70.36. Highlighting a potential decline of 48.42% , cautious investment and vigilant monitoring become paramount. In the grand scheme, a price oscillation channel for Moderna is foreseeable, bounded by a resistance level of $ 103.57 and a support frontier at $ 70.36 . MODERNA Stock Forecast, 0QF stock price prediction. Price target in 14 days: 72.954 EUR. The best long-term & short-term MODERNA share price prognosis for 2023, 2024 ...For Uber Technologies stock forecast for 2033 (10 year), 11 predictions are offered for each month of 2033 with average Uber Technologies stock forecast of $34.23, a high forecast of $34.52, and a low forecast of $34.07. The average Uber Technologies stock forecast 2033 represents a -37.13% decrease from the last price of $54.439998626709.In the dynamic world of stock trading, analysts and investors closely observe the projected highs and lows of Moderna shares. Our integrated forecast predicts a peak price of $72.91 in the forthcoming 30 days, indicating the zenith of the stock's potential performance. An encouraging revelation, denoting an upside potential of 1.39% from the …

Long-term MRNA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050. Our analysts are offering long term price forecasts for Moderna INC In 2050, the median target price for MRNA is $2,409.44, with a high estimate of $2,414.58 and a low estimate of $2,101.18. The median estimate represents a +3,171% increase from the last price of $73.66 ...

Nov 2, 2023 · Moderna ( MRNA) stock tumbled Thursday after the Covid vaccine maker handily beat third-quarter sales forecasts, but reported bigger-than-expected losses and issued light guidance for this year ... Moderna stock currently trades at a mere 12x 2021 consensus earnings. The conservative multiple is largely due to the fact that investors expect sales of the Covid vaccine – Moderna’s only ...JPMorgan Adjusts Moderna Price Target to $90 From $93, Maintains Neutral Rating MT Nov. 30: Transcript : Moderna, Inc. Presents at Piper Sandler 35th Annual Healthcare Conference, Nov-30-2023 12:30 PM CIStock analysis for Moderna Inc (MRNA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Stock analysis for Moderna Inc (MRNA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Moderna Struggles With Weaker COVID-19 Vaccine Demand, Expects To Return To Growth In 2025, Stock Plunges. shares are trading lower after the company reported a deeper Q3 loss of $ (9.53), down ...Are you a long-term investor and curious about the potential prices of popular stocks in 2025? Then, this page is for you! Markets: DJIA + 700.53 2.13%. NASDAQ + 264.05 2.56%. S&P ...The Company has advanced six programs into late-stage development, including two approved or filed for approval, and three more that have completed Phase 3 enrollment. The Company expects to double the number of programs in Phase 3 by 2025 and launch up to 15 products in five years across cancer, rare disease, and infectious disease.MODERNA () Stock Market info Recommendations: Buy or sell MODERNA stock? Stuttgart Stock Market & Finance report, prediction for the future: You'll find the MODERNA share forecasts, stock quote and buy / sell signals below.According to present data MODERNA's 0QF shares and potentially its market environment have been in bearish …The consensus revenue forecast for Moderna in 2023 is a little under half the anticipated sales the company should generate this year. ... Its CMV data could be ready by 2025. ... Moderna's Stock ...

217.25 -56.03% Year-to-Date Quote Profile News Charts Forecasts Financials Shareholders Competitors vs. Health Technology News Chart Latest MRNA News | …

Moderna Inc () Stock Market info Recommendations: Buy or sell Moderna stock? London Stock Market & Finance report, prediction for the future: You'll find the Moderna share forecasts, stock quote and buy / sell signals below.According to present data Moderna's 0A45 shares and potentially its market environment have been in bearish cycle last 12 …

About the The Walt Disney Co. stock forecast. As of 2023 December 01, Friday current price of DIS stock is 92.210$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Walt Disney Co (The) stock price has been showing a declining tendency so we believe that similar market segments …Forecasts are adjusted once a day taking into account the price change of the previous day. To date, analysts have a $82.55 target price for Square stock stock. Today 200 Day Moving Average is the resistance level (66.49 $). 50 Day Moving Average is the resistance level (61.21 $). 2023.Whether you bought MRNA stock for the CMV or the coronavirus catalyst, it’s time to sell. Upside potential is now priced into shares. Luke Lango Issues Dire Warning A $15.7 trillion tech melt could be triggered as soon as June 14th… Now is ...See Moderna, Inc. (MRNA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Best REITs to Buy Now. IPO Stocks. Penny StocksModerna (MRNA) stock is rising on Wednesday as the Covid-19 vaccine company reports earnings for the second quarter of 2022. MRNA has more vaccines in development Moderna (NASDAQ:MRNA) stock is rising on Wednesday as the vaccine company rep...Moderna said on Thursday its 2023 sales would only hit the low end of its previous forecast, reflecting weaker demand for COVID-19 vaccines and its shares plummeted over 16% in early trade. The ...Moderna stock price forecast on Thursday, December, 14: 78.98 dollars, maximum 85.30, minimum 72.66. Moderna Stock Price Prediction 2023, 2024, 2025. Nikola Price Prediction Tomorrow & Month.

Moderna stock forecast 2025： MRNA is worth buying for 5 reasons. September 07, 2021 Moderna was founded in 2009 and was established in Cambridge, Massachusetts, USA. Its main business is genetic engineering and focuses on the research and development of mRNA-derived drugs. The full name of mRNA is messenger RNA, …As far as the long-term Moderna stock forecast is concerned, here’s what our predictions are currently suggesting. These predictions are based on the 10-year average growth of MRNA. Moderna stock prediction for 1 year from now: $ 275.30 (254.31%) Moderna stock forecast for 2025: $ 290.97 (274.48%)Dec 16, 2022 · In 2030, we may expect an average value of $5.71 for Sorrento Therapeutics. If the market gets bullish, SRNE stock may surge more than our forecast. The maximum value of SRNE can be around $6.08 in 2030. However, the minimum value of Sorrento Therapeutics can be around $5.14 if the market turns bearish. Moderna on Thursday said it expected 2023 revenue of at least $6 billion, tempering its forecast to reflect weaker demand for COVID-19 vaccines, but added it would return to sales growth in 2025 ...Instagram:https://instagram. snowflake forecastfmeixnasdaq omh newsgood banking apps Based on short-term price targets offered by 16 analysts, the average price target for Moderna comes to $141.43. The forecasts range from a low of $52.00 to a high of $300.00. The average price ... forex trading softwaresbest account for day trading JPMorgan Chase & Co. () Stock Market info Recommendations: Buy or sell JPMorgan Chase & stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the JPMorgan Chase & share forecasts, stock quote and buy / sell signals below.According to present data JPMorgan Chase &'s JPM shares and potentially its … ilmn stock forecast The latest Moderna stock prices, stock quotes, news, and MRNA history to help you invest and trade smarter. ... The 53 analysts offering price forecasts for Moderna have a median target of 163.42 ...Moderna Stock Price Prediction 2025 is $110; Moderna Stock Price Prediction 2026 is $142; Moderna Stock Price Prediction 2027 is $164; Moderna Stock Price Prediction 2028 is $187; ... Moderna Stock Forecast 2023: Fundamentals. Investors in Moderna stock had a mixed experience during the fourth quarter. Despite a 29.5% …